NASDAQ:MNKD

Mannkind Stock Predictions

Healthcare > Biotechnology

Buy MNKD

*Your capital is at risk

$3.36

-0.0700 (-2.04%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

MNKD Prediction Chart

MNKD Predictions History

Latest community submissions for MNKD.

Predictor	Target Session	Target Price	Result	Direction	Accuracy
YoungBulls	Jan 27, 2017	$0.694 -79.25%	$0.670	V	96.30%
JS Pro	Jan 10, 2017	$0.616 -80.83%	$0.640	V	96.20%
Abhi.1744	Dec 7, 2016	$1.20 -61.34%	$0.620	V	6.50%
Mohammad.Hamzeh.1653	Nov 25, 2016	$0.610 -77.95%	$0.550	V	89.10%

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for MNKD with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT MANNKIND CORPORATION

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocrinologists, and other healthcare providers for the treatment of hypothyroidism. The company has a licens...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by